1,7-phenanthroline has been researched along with Experimental Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Cheng, YC | 1 |
| Laycock, GA; Shulman, A | 1 |
| Cohen, PS; Smith, SD | 1 |
3 other study(ies) available for 1,7-phenanthroline and Experimental Leukemia
| Article | Year |
|---|---|
Ribonucleotide reductase isolated from human cells. Heterogeneity among the sources.
Topics: Adenosine Diphosphate; Animals; Cells; Cytidine Diphosphate; HeLa Cells; Humans; Hydroxyurea; Isoquinolines; Leukemia, Experimental; Phenanthrolines; Potassium Chloride; Ribonucleotide Reductases | 1978 |
Action of 1,10-phenanthroline transition metal chelates on P388 mouse lymphocyte leukaemic cells.
Topics: Animals; Ascites; Cells, Cultured; Chelating Agents; Drug Resistance; Leukemia, Experimental; Leukemia, Lymphoid; Ligands; Metals; Mice; Mice, Inbred BALB C; Phenanthrolines | 1977 |
In vitro and in vivo chemotherapy screening of the divalent cation chelator 1,10-orthophenanthroline.
Topics: Animals; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hematopoietic Stem Cells; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Magnesium; Mice; Phenanthrolines; T-Lymphocytes; Time Factors; Zinc | 1985 |